Literature DB >> 20463101

Analytical and biological considerations in the measurement of cell-associated CCR5 and CXCR4 mRNA and protein.

D E Campbell1, J P Lai, N B Tustin, E Riedel, R Tustin, J Taylor, J Murray, S D Douglas.   

Abstract

The accurate measurement of T cell-associated CC chemokine receptor type 5 (CCR5) and CXC chemokine receptor type 4 (CXCR4) expression, including expression of CCR5 and CXCR4 mRNA as an immune measure of immunologic response to highly active antiretroviral therapy (HAART) and newer agents, including entry inhibitors, is essential. Previous studies have reported alterations in lymphocyte cell membrane CCR5 expression that were related to blood collection and cell separation media. Clinical trials often require the transport of specimens to central laboratories for evaluation, resulting in significant time delays between specimen procurement and analysis. This study shows that CCR5 expression on naïve and memory T cells is influenced by blood collection media and specimen age. Peripheral blood collected in Streck Vacutainer tubes containing a cell stabilizer and fixative was found to improve detection of CCR5 expression compared to specimens collected in K2 EDTA anticoagulant. The selection of flow cytometry gating strategies for the identification of naïve and memory T-helper cells can also significantly influence the sensitivity of detection of CCR5 expression. Procedural methods are described that allow for the optimal measurement of naïve and memory T-helper cell CCR5 and CXCR4 expression as well as the quantitation of CCR5 and CXCR4 mRNA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463101      PMCID: PMC2897254          DOI: 10.1128/CVI.00533-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  17 in total

1.  Optimized lymphocyte isolation methods for analysis of chemokine receptor expression.

Authors:  Della Berhanu; Frank Mortari; Stephen C De Rosa; Mario Roederer
Journal:  J Immunol Methods       Date:  2003-08       Impact factor: 2.303

2.  Structure of a V3-containing HIV-1 gp120 core.

Authors:  Chih-chin Huang; Min Tang; Mei-Yun Zhang; Shahzad Majeed; Elizabeth Montabana; Robyn L Stanfield; Dimiter S Dimitrov; Bette Korber; Joseph Sodroski; Ian A Wilson; Richard Wyatt; Peter D Kwong
Journal:  Science       Date:  2005-11-11       Impact factor: 47.728

3.  Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy.

Authors:  Ruy M Ribeiro; Mette D Hazenberg; Alan S Perelson; Miles P Davenport
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Molecular switch for alternative conformations of the HIV-1 V3 region: implications for phenotype conversion.

Authors:  Osnat Rosen; Michal Sharon; Sabine R Quadt-Akabayov; Jacob Anglister
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

5.  Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.

Authors:  E L Murphy; A C Collier; L A Kalish; S F Assmann; M F Para; T P Flanigan; P N Kumar; L Mintz; F R Wallach; G J Nemo
Journal:  Ann Intern Med       Date:  2001-07-03       Impact factor: 25.391

6.  HIV gp120-induced interaction between CD4 and CCR5 requires cholesterol-rich microenvironments revealed by live cell fluorescence resonance energy transfer imaging.

Authors:  Ling Yi; Jun Fang; Nilgun Isik; Jimmy Chim; Tian Jin
Journal:  J Biol Chem       Date:  2006-09-08       Impact factor: 5.157

Review 7.  Chemokine antagonists as therapeutics: focus on HIV-1.

Authors:  Athe M N Tsibris; Daniel R Kuritzkes
Journal:  Annu Rev Med       Date:  2007       Impact factor: 13.739

Review 8.  Biology of CCR5 and its role in HIV infection and treatment.

Authors:  Michael M Lederman; Adam Penn-Nicholson; Michael Cho; Donald Mosier
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

9.  Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211.

Authors:  Zhaohui Su; Roy M Gulick; Amy Krambrink; Eoin Coakley; Michael D Hughes; Dong Han; Charles Flexner; Timothy J Wilkin; Paul R Skolnik; Wayne L Greaves; Daniel R Kuritzkes; Jacqueline D Reeves
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

10.  Quantification of CCR5 mRNA in human lymphocytes and macrophages by real-time reverse transcriptase PCR assay.

Authors:  Jian-Ping Lai; Ji-Hong Yang; Steven D Douglas; Xu Wang; Eric Riedel; Wen-Zhe Ho
Journal:  Clin Diagn Lab Immunol       Date:  2003-11
View more
  2 in total

1.  The frequency of α₄β₇(high) memory CD4⁺ T cells correlates with susceptibility to rectal simian immunodeficiency virus infection.

Authors:  Elena Martinelli; Filippo Veglia; Diana Goode; Natalia Guerra-Perez; Meropi Aravantinou; James Arthos; Michael Piatak; Jeffrey D Lifson; James Blanchard; Agegnehu Gettie; Melissa Robbiani
Journal:  J Acquir Immune Defic Syndr       Date:  2013-12-01       Impact factor: 3.731

2.  Sex hormones selectively impact the endocervical mucosal microenvironment: implications for HIV transmission.

Authors:  Diana Goode; Meropi Aravantinou; Sebastian Jarl; Rosaline Truong; Nina Derby; Natalia Guerra-Perez; Jessica Kenney; James Blanchard; Agegnehu Gettie; Melissa Robbiani; Elena Martinelli
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.